NBTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nanobiotix SA (NBTX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the technical indicators show bullish momentum, there is no strong signal from proprietary trading tools, no recent news catalysts, and hedge funds are heavily selling. The lack of financial performance data and valuation metrics also makes it difficult to assess the company's long-term potential. A 'hold' is recommended until more clarity emerges.
The technical indicators for NBTX show bullish momentum. The MACD histogram is positive and expanding (0.193), the RSI (72.878) is in the neutral zone, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The pre-market price of $27.51 is above the pivot level ($26.083) and near the first resistance level (R1: $27.435), suggesting limited immediate upside.
TD Cowen initiated coverage with a Buy rating, citing the company's physics-based platform technologies and broad applicability across tumor types.
Hedge funds are heavily selling, with a 1048.78% increase in selling activity over the last quarter. No recent news or congress trading data is available to support positive sentiment.
No financial performance data is available for analysis.
TD Cowen initiated coverage with a Buy rating but did not provide a price target. The analyst sees upside potential as the company expands into more tumor types.
